DHR · News · 20261030N

Point-of-Care INR Testing Market Growth

DANAHER CORP /DE/ · 2026-10-30 · Importance 30 · Surprise 40

A market report identified Danaher, Abbott, Roche and Siemens Healthineers among companies scaling home monitoring in point-of-care international normalized ratio (INR) testing. It cited demand drivers including cardiovascular disease prevalence, anticoagulant therapy use and demand for faster coagulation testing. The global market is projected to grow from $1.58 billion in 2025 to $1.75 billion in 2026, a 10.4% CAGR.